Prostrate Cancer Metastasis – Scalp Metastasis of Prostate Cancer

June 26, 2009 by  
Filed under Prostate Cancer

Do You Want To Make Money Online?


You Will Be Blown Away

Scalp metastasis of prostate cancer is not a common occurrence in the physiological progression of the adenocarcinoma, although it is not totally impossible. Prostate tumors, after they have been in the prostate for a while begin to infiltrate the bloodstream and lymphatic system, and then they start to metastasize to other regions of the body. They appear to have a preference for the bones, where they cause hot and cold spots in which the bones have grown denser or more brittle as a consequence; and they cause intense bone pain, especially in the proximal part of the bone.

The bones most usually attacked by this form of prostate cancer progression are the pelvic bone, the femur, the bones of the spinal column, and the ribs. However, in certain extremes, foot and skull metastasis does occur, which only serves to worsen the symptoms observed from the syndrome.

In order to confirm bone metastasis of prostate cancer, it would be necessary to carry out a bone scan of the suspected regions. Along with the MRI and CT scans to assert that the cancer has indeed spread to various other regions of the body, a test of tissue extracted from the scalp will likely be needed to confirm that the lesions appearing on the head are indeed metastatic prostate cancer.

The chances of curing a prostate cancer that widespread are almost zero because of the envisioned degree of spread and the implied aggression of the disease. Most likely, this patient would have been undergoing some other form of treatment by this time, meaning that the progression of the cancer has proven resistant to the proffered remedies. In this wise, treatment will have to constitute an aggressive combination of the known therapies for prostate cancer. Hormonal therapy may work to slow or reverse the progress of the disease, but considering that it might have grown into a belligerent form of hormone refractory prostate cancer (HRPCa), immunotherapy will perhaps be a better option.

Immune treatments are intended to boost the body’s immune system to fight the disease by itself, and they are at least sure to slow the time taken for PSAs in the patient’s blood to double. Chemotherapy will combat as many of the cancer cells as it can catch, and delay the symptoms of the disorder; while radiation therapy will help to alleviate the intense pain that the patient is bound to be enduring.

Pamidronate and zoledronic acid are bisphosphonate drugs sold as Aredia and Zometa respectively in the United States. They are FDA approved medications that are meant to help bone pain for aggressive metastatic hormone refractory prostate cancer. They may be administered also to help the patient manage better.

Such is the case in the instance of late stage IV (stage 4) prostate cancer. The disease is not perceived as curable and treatment is centered toward being palliative, which focuses on extending life and relieving the symptoms of metastatic disease.

Below Are Other Related Articles Among 1,000+ Prostate Cancer Articles On
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:

(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)


  1. Stage IV Prostate Cancer – Bone Metastasis Treatment and Prognosis
  2. Metastasis Prostate Cancer
  3. Cancer De La Prostate Et Ses Metastases – Metastasis and Treatment by Chemotherapy
  4. Metastasis Prostate Cancer

Speak Your Mind

Tell us what you're thinking... !

s